Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TREASURIES-Yields lower, curve flatter ahead of Fed

Fri, 11th Dec 2020 21:23

(New throughout)
By Kate Duguid
NEW YORK, Dec 11 (Reuters) - A risk-off move drove Treasury
yields down across maturities on Friday, with the two-year yield
falling to a four-month low, furthering speculation that the
Federal Reserve may announce adjustments to its Treasury
purchases at next week's meeting.
The fall in yields was partly attributable to reports that
congressional wrangling over a spending package and coronavirus
aid could drag on through Christmas. Also pulling yields lower
was news that European pharmaceutical companies Sanofi SA
and GlaxoSmithKline Plc would delay the launch
of their COVID-19 vaccine until late next year, a setback in the
global fight against the pandemic.
Those macroeconomic drivers explain the fall in the
benchmark 10-year yield and the 30-year bond yield
to their lowest since Dec. 1. In afternoon trade,
both had pulled back from those lows, with the 10-year last down
1.5 basis points at 0.892% and the 30-year down 1.4 basis points
at 1.622%.
The move in the two-year yield to its lowest
since Aug. 7, however, was surprising, as the yield has been
roughly anchored since the Fed moved interest rates to zero at
the beginning of the pandemic. It was last down 2 basis points
at 0.119%.
Analysts argued the two-year move was likely not purely the
result of macroeconomic drivers. Yields on Treasury bills - debt
with a maturity of one year or less - are all less than 10 basis
points away from 0%, according to Tradeweb data.
"The idea that bills could potentially go to zero is taking
twos, threes and fives along with it," said Justin Lederer,
Treasury analyst and trader at Cantor Fitzgerald.
Since the lows hit in March, the 10-year yield has risen
more than 60 basis points, and the 30-year has risen nearly 100.
The two-year yield, by comparison, was just a basis point and a
half higher than the all-time low it hit in May.
Both long rates have increased enough in the past several
months that some analysts believe the Fed will purchase more
longer-dated debt to cap yields and keep borrowing costs low.
Since March the Fed has bought more than $2 trillion worth of
Treasury debt, most of it in shorter-dated notes.
If the Fed were to lengthen the average maturity of its
Treasury holdings - by purchasing the same amount but buying
more longer-dated debt and less shorter-dated debt - it could
also have the effect of bolstering Treasury bills and
shorter-dated notes away from zero.
"I can see the Fed trying to do something to alleviate that.
They definitely don't want bills trading negative, or repo
trading negative," said Lederer.

December 11 Friday 4:14PM New York / 2114 GMT
Price Current Net
Yield % Change
(bps)
Three-month bills 0.0725 0.0735 -0.006
Six-month bills 0.0825 0.0837 0.000
Two-year note 100-3/256 0.119 -0.020
Three-year note 99-216/256 0.1772 -0.019
Five-year note 100-16/256 0.3623 -0.021
Seven-year note 100 0.625 -0.021
10-year note 99-212/256 0.8931 -0.015
20-year bond 99-76/256 1.4156 -0.016
30-year bond 100-12/256 1.623 -0.013

DOLLAR SWAP SPREADS
Last (bps) Net
Change
(bps)
U.S. 2-year dollar swap 7.50 0.25
spread
U.S. 3-year dollar swap 6.00 0.00
spread
U.S. 5-year dollar swap 5.50 0.00
spread
U.S. 10-year dollar swap -1.00 -0.50
spread
U.S. 30-year dollar swap -29.00 -1.00
spread


(Reporting by Kate Duguid; Editing by Ken Ferris and Jonathan
Oatis)

More News
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.